Clinical Trial Update: Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product

View source ↗

Summary

This clinical trial update provides long-term follow-up data for participants with cerebral adrenoleukodystrophy who were treated with the Lenti-D gene therapy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenoleukodystrophy
• Cerebral Adrenoleukodystrophy
• X-linked Adrenoleukodystrophy

Drugs mentioned

• Lenti-D (elivaldogene autotemcel)

Snippet

Sponsor: Genetix Biotherapeutics Inc. | Conditions: Cerebral Adrenoleukodystrophy (CALD), Adrenoleukodystrophy (ALD) | Status: ACTIVE_NOT_RECRUITING